|
G |
Cat |
catalase |
multiple interactions |
ISO |
[Hydrogen Peroxide co-treated with Quinic Acid analog] results in increased expression of CAT mRNA |
CTD |
PMID:21751221 |
|
NCBI chr 3:89,842,393...89,874,577
Ensembl chr 3:89,842,399...89,874,478
|
|
G |
Ddit3 |
DNA-damage inducible transcript 3 |
multiple interactions |
ISO |
[Hydrogen Peroxide co-treated with Quinic Acid analog] results in increased expression of DDIT3 mRNA |
CTD |
PMID:21751221 |
|
NCBI chr 7:63,115,645...63,121,203
Ensembl chr 7:63,116,380...63,121,201
|
|
G |
Ercc1 |
ERCC excision repair 1, endonuclease non-catalytic subunit |
multiple interactions |
ISO |
[Hydrogen Peroxide co-treated with Quinic Acid analog] results in increased expression of ERCC1 mRNA |
CTD |
PMID:21751221 |
|
NCBI chr 1:78,971,310...79,007,963
Ensembl chr 1:78,996,390...79,007,963
|
|
G |
Gadd45a |
growth arrest and DNA-damage-inducible, alpha |
multiple interactions |
ISO |
[Hydrogen Peroxide co-treated with Quinic Acid analog] results in increased expression of GADD45A mRNA |
CTD |
PMID:21751221 |
|
NCBI chr 4:96,154,789...96,157,091
Ensembl chr 4:96,154,789...96,157,115
|
|
G |
Gpx1 |
glutathione peroxidase 1 |
multiple interactions |
ISO |
[Hydrogen Peroxide co-treated with Quinic Acid analog] results in decreased expression of GPX1 mRNA |
CTD |
PMID:21751221 |
|
NCBI chr 8:109,026,905...109,028,031
Ensembl chr 8:109,026,905...109,028,024
|
|
G |
Gss |
glutathione synthetase |
multiple interactions |
ISO |
[Hydrogen Peroxide co-treated with Quinic Acid analog] results in increased expression of GSS mRNA |
CTD |
PMID:21751221 |
|
NCBI chr 3:144,047,849...144,078,197
Ensembl chr 3:144,047,850...144,078,198
|
|
G |
Hmox2 |
heme oxygenase 2 |
multiple interactions |
ISO |
[Hydrogen Peroxide co-treated with Quinic Acid analog] results in increased expression of HMOX2 mRNA |
CTD |
PMID:21751221 |
|
NCBI chr10:10,797,076...10,831,178
Ensembl chr10:10,797,055...10,831,148
|
|
G |
Lig4 |
DNA ligase 4 |
multiple interactions |
ISO |
[Hydrogen Peroxide co-treated with Quinic Acid analog] results in increased expression of LIG4 mRNA |
CTD |
PMID:21751221 |
|
NCBI chr16:79,518,393...79,526,956
Ensembl chr16:79,518,312...79,527,040
|
|
G |
Msh2 |
mutS homolog 2 |
multiple interactions |
ISO |
[Hydrogen Peroxide co-treated with Quinic Acid analog] results in increased expression of MSH2 mRNA |
CTD |
PMID:21751221 |
|
NCBI chr 6:6,813,793...6,872,960
Ensembl chr 6:6,813,795...6,872,938
|
|
G |
Pcna |
proliferating cell nuclear antigen |
multiple interactions |
ISO |
[Hydrogen Peroxide co-treated with Quinic Acid analog] results in increased expression of PCNA mRNA |
CTD |
PMID:21751221 |
|
NCBI chr 3:119,499,039...119,502,911
Ensembl chr 3:119,498,810...119,502,995
|
|
G |
Pold2 |
DNA polymerase delta 2, accessory subunit |
multiple interactions |
ISO |
[Hydrogen Peroxide co-treated with Quinic Acid analog] results in increased expression of POLD2 mRNA |
CTD |
PMID:21751221 |
|
NCBI chr14:80,748,971...80,755,188
Ensembl chr14:80,748,974...80,755,160
|
|
G |
Prdx4 |
peroxiredoxin 4 |
multiple interactions |
ISO |
[Hydrogen Peroxide co-treated with Quinic Acid analog] results in increased expression of PRDX4 mRNA |
CTD |
PMID:21751221 |
|
NCBI chr X:40,026,762...40,044,066
Ensembl chr X:40,026,651...40,044,066
|
|
G |
Rpa2 |
replication protein A2 |
multiple interactions |
ISO |
[Hydrogen Peroxide co-treated with Quinic Acid analog] results in increased expression of RPA2 mRNA |
CTD |
PMID:21751221 |
|
NCBI chr 5:144,976,789...144,989,445
Ensembl chr 5:144,976,748...144,987,350
|
|
G |
Rpa3 |
replication protein A3 |
multiple interactions |
ISO |
[Hydrogen Peroxide co-treated with Quinic Acid analog] results in increased expression of RPA3 mRNA |
CTD |
PMID:21751221 |
|
NCBI chr 4:36,304,649...36,307,755
Ensembl chr 4:36,304,651...36,307,709
|
|
G |
Tdg |
thymine-DNA glycosylase |
multiple interactions |
ISO |
[Hydrogen Peroxide co-treated with Quinic Acid analog] results in increased expression of TDG mRNA |
CTD |
PMID:21751221 |
|
NCBI chr 7:21,077,853...21,097,617
Ensembl chr 7:21,077,853...21,097,567
|
|
G |
Txn1 |
thioredoxin 1 |
multiple interactions |
ISO |
[Hydrogen Peroxide co-treated with Quinic Acid analog] results in increased expression of TXN mRNA |
CTD |
PMID:21751221 |
|
NCBI chr 5:72,712,334...72,724,564
Ensembl chr 5:72,711,933...72,724,629
|
|
G |
Txnrd1 |
thioredoxin reductase 1 |
multiple interactions |
ISO |
[Hydrogen Peroxide co-treated with Quinic Acid analog] results in increased expression of TXNRD1 mRNA |
CTD |
PMID:21751221 |
|
NCBI chr 7:20,830,042...20,914,990
Ensembl chr 7:20,830,045...20,907,863
|
|
G |
Xpa |
XPA, DNA damage recognition and repair factor |
multiple interactions |
ISO |
[Hydrogen Peroxide co-treated with Quinic Acid analog] results in increased expression of XPA mRNA |
CTD |
PMID:21751221 |
|
NCBI chr 5:60,431,673...60,475,726
Ensembl chr 5:60,431,673...60,475,726
|
|
G |
Xrcc1 |
X-ray repair cross complementing 1 |
multiple interactions |
ISO |
[Hydrogen Peroxide co-treated with Quinic Acid analog] results in increased expression of XRCC1 mRNA |
CTD |
PMID:21751221 |
|
NCBI chr 1:80,140,495...80,168,705
Ensembl chr 1:80,141,207...80,168,701
|
|
G |
Xrcc5 |
X-ray repair cross complementing 5 |
multiple interactions |
ISO |
[Hydrogen Peroxide co-treated with Quinic Acid analog] results in increased expression of XRCC5 mRNA |
CTD |
PMID:21751221 |
|
NCBI chr 9:73,955,216...74,044,020
Ensembl chr 9:73,955,216...74,044,018
|
|
|
G |
Fth1 |
ferritin heavy chain 1 |
increases expression multiple interactions |
ISO |
3-O-caffeoyl-1-methylquinic acid results in increased expression of FTH1 mRNA Buthionine Sulfoximine promotes the reaction [3-O-caffeoyl-1-methylquinic acid results in increased expression of FTH1 mRNA]; Carmustine inhibits the reaction [3-O-caffeoyl-1-methylquinic acid results in increased expression of FTH1 mRNA]; Glutathione inhibits the reaction [3-O-caffeoyl-1-methylquinic acid results in increased expression of FTH1 mRNA] |
CTD |
PMID:16631525 |
|
NCBI chr 1:206,627,142...206,629,430
Ensembl chr 1:206,627,103...206,725,424
|
|
G |
Gclc |
glutamate-cysteine ligase, catalytic subunit |
multiple interactions increases expression |
ISO |
Acetylcysteine inhibits the reaction [3-O-caffeoyl-1-methylquinic acid results in increased expression of GCLC mRNA] |
CTD |
PMID:16631525 |
|
NCBI chr 8:78,629,899...78,668,547
Ensembl chr 8:78,630,127...78,668,544
|
|
G |
Gsr |
glutathione-disulfide reductase |
increases expression multiple interactions |
ISO |
3-O-caffeoyl-1-methylquinic acid results in increased expression of GSR mRNA Acetylcysteine inhibits the reaction [3-O-caffeoyl-1-methylquinic acid results in increased expression of GSR mRNA] |
CTD |
PMID:16631525 |
|
NCBI chr16:58,482,209...58,525,256
Ensembl chr16:58,482,505...58,525,661
|
|
G |
Hmox1 |
heme oxygenase 1 |
multiple interactions increases expression |
ISO |
Acetylcysteine inhibits the reaction [3-O-caffeoyl-1-methylquinic acid results in increased expression of HMOX1 mRNA]; Buthionine Sulfoximine promotes the reaction [3-O-caffeoyl-1-methylquinic acid results in increased expression of HMOX1 mRNA]; Carmustine inhibits the reaction [3-O-caffeoyl-1-methylquinic acid results in increased expression of HMOX1 mRNA]; Glutathione inhibits the reaction [3-O-caffeoyl-1-methylquinic acid results in increased expression of HMOX1 mRNA]; pyrazolanthrone inhibits the reaction [3-O-caffeoyl-1-methylquinic acid results in increased expression of HMOX1 protein] 3-O-caffeoyl-1-methylquinic acid results in increased expression of HMOX1 mRNA; 3-O-caffeoyl-1-methylquinic acid results in increased expression of HMOX1 protein |
CTD |
PMID:16631525 |
|
NCBI chr19:13,466,287...13,474,082
Ensembl chr19:13,467,244...13,474,079
|
|
G |
Mapk1 |
mitogen activated protein kinase 1 |
increases phosphorylation |
ISO |
3-O-caffeoyl-1-methylquinic acid results in increased phosphorylation of MAPK1 protein |
CTD |
PMID:16631525 |
|
NCBI chr11:83,957,813...84,023,629
Ensembl chr11:83,957,813...84,023,616
|
|
G |
Mapk3 |
mitogen activated protein kinase 3 |
increases phosphorylation |
ISO |
3-O-caffeoyl-1-methylquinic acid results in increased phosphorylation of MAPK3 protein |
CTD |
PMID:16631525 |
|
NCBI chr 1:181,366,646...181,372,863
Ensembl chr 1:181,366,637...181,372,863
|
|
G |
Mapk8 |
mitogen-activated protein kinase 8 |
increases phosphorylation |
ISO |
3-O-caffeoyl-1-methylquinic acid results in increased phosphorylation of MAPK8 protein |
CTD |
PMID:16631525 |
|
NCBI chr16:8,638,897...8,721,960
Ensembl chr16:8,638,924...8,721,981
|
|
G |
Mapk9 |
mitogen-activated protein kinase 9 |
increases phosphorylation |
ISO |
3-O-caffeoyl-1-methylquinic acid results in increased phosphorylation of MAPK9 protein |
CTD |
PMID:16631525 |
|
NCBI chr10:34,169,661...34,211,138
Ensembl chr10:34,169,675...34,210,178
|
|
G |
Nfe2l2 |
NFE2 like bZIP transcription factor 2 |
affects localization multiple interactions |
ISO |
3-O-caffeoyl-1-methylquinic acid affects the localization of NFE2L2 protein Acetylcysteine inhibits the reaction [3-O-caffeoyl-1-methylquinic acid affects the localization of NFE2L2 protein]; Glutathione inhibits the reaction [3-O-caffeoyl-1-methylquinic acid affects the localization of NFE2L2 protein]; pyrazolanthrone inhibits the reaction [3-O-caffeoyl-1-methylquinic acid affects the localization of NFE2L2 protein] |
CTD |
PMID:16631525 |
|
NCBI chr 3:60,594,239...60,621,712
Ensembl chr 3:60,594,242...60,621,737
|
|
|
G |
Abcc1 |
ATP binding cassette subfamily C member 1 |
multiple interactions |
ISO |
Chlorogenic Acid inhibits the reaction [Cisplatin results in increased expression of ABCC1 protein] |
CTD |
PMID:25043994 |
|
NCBI chr10:528,961...655,179
Ensembl chr10:531,812...655,114
|
|
G |
Abcc2 |
ATP binding cassette subfamily C member 2 |
multiple interactions |
ISO |
Chlorogenic Acid inhibits the reaction [Cisplatin results in increased expression of ABCC2 protein] |
CTD |
PMID:25043994 |
|
NCBI chr 1:242,664,657...242,723,239
Ensembl chr 1:242,664,657...242,723,238
|
|
G |
Ache |
acetylcholinesterase |
decreases activity |
ISO |
Chlorogenic Acid results in decreased activity of ACHE protein |
CTD |
PMID:20854806 |
|
NCBI chr12:19,406,133...19,413,713
Ensembl chr12:19,407,360...19,413,651
|
|
G |
Acly |
ATP citrate lyase |
increases expression |
ISO |
Chlorogenic Acid results in increased expression of ACLY mRNA |
CTD |
PMID:20706672 |
|
NCBI chr10:85,412,045...85,464,253
Ensembl chr10:85,412,049...85,463,320
|
|
G |
Acta2 |
actin alpha 2, smooth muscle |
multiple interactions |
EXP |
Chlorogenic Acid inhibits the reaction [Carbon Tetrachloride results in increased expression of ACTA2 mRNA]; Chlorogenic Acid inhibits the reaction [Carbon Tetrachloride results in increased expression of ACTA2 protein] |
CTD |
PMID:23146752 |
|
NCBI chr 1:231,746,527...231,759,307
Ensembl chr 1:231,746,548...231,759,554
|
|
G |
Akt1 |
AKT serine/threonine kinase 1 |
multiple interactions |
ISO |
Chlorogenic Acid inhibits the reaction [Rotenone results in decreased phosphorylation of AKT1 protein] |
CTD |
PMID:36048341 |
|
NCBI chr 6:131,713,716...131,735,319
Ensembl chr 6:131,713,720...131,733,921
|
|
G |
Alb |
albumin |
multiple interactions |
EXP ISO |
Chlorogenic Acid inhibits the reaction [Carbon Tetrachloride results in decreased expression of ALB protein] Chlorogenic Acid affects the reaction [2,2'-azobis(2-amidinopropane) results in increased degradation of ALB protein] |
CTD |
PMID:11322927 PMID:23146752 |
|
NCBI chr14:17,607,397...17,622,814
Ensembl chr14:17,607,381...17,622,836
|
|
G |
Aqp1 |
aquaporin 1 |
increases expression |
ISO |
Chlorogenic Acid results in increased expression of AQP1 mRNA |
CTD |
PMID:20706672 |
|
NCBI chr 4:84,482,512...84,494,690
Ensembl chr 4:84,482,512...84,494,690
|
|
G |
Aqp3 |
aquaporin 3 (Gill blood group) |
increases expression |
ISO |
Chlorogenic Acid results in increased expression of AQP3 mRNA |
CTD |
PMID:20706672 |
|
NCBI chr 5:56,239,200...56,244,718
Ensembl chr 5:56,239,201...56,244,720
|
|
G |
Ar |
androgen receptor |
decreases expression |
ISO |
Chlorogenic Acid results in decreased expression of AR mRNA |
CTD |
PMID:20706672 |
|
NCBI chr X:63,104,771...63,273,934
Ensembl chr X:63,104,771...63,273,925
|
|
G |
Atf4 |
activating transcription factor 4 |
multiple interactions |
EXP |
Chlorogenic Acid inhibits the reaction [Glucose results in increased expression of ATF4 protein] |
CTD |
PMID:34801538 |
|
NCBI chr 7:111,804,135...111,806,457
Ensembl chr 7:111,804,183...111,806,446
|
|
G |
Atf6 |
activating transcription factor 6 |
multiple interactions |
EXP |
Chlorogenic Acid inhibits the reaction [[Streptozocin co-treated with Dietary Fats co-treated with Fructose] results in increased expression of ATF6 protein]; Chlorogenic Acid inhibits the reaction [Glucose results in increased expression of ATF6 protein] |
CTD |
PMID:34801538 |
|
NCBI chr13:82,927,579...83,106,381
Ensembl chr13:82,930,034...83,107,177
|
|
G |
Bambi |
BMP and activin membrane-bound inhibitor |
multiple interactions |
EXP |
Chlorogenic Acid inhibits the reaction [Carbon Tetrachloride results in decreased expression of BAMBI mRNA]; Chlorogenic Acid inhibits the reaction [Carbon Tetrachloride results in decreased expression of BAMBI protein] |
CTD |
PMID:23146752 |
|
NCBI chr17:54,121,251...54,125,816
Ensembl chr17:54,121,255...54,126,060
|
|
G |
Bax |
BCL2 associated X, apoptosis regulator |
multiple interactions increases expression |
ISO EXP |
Chlorogenic Acid inhibits the reaction [Aluminum Chloride results in increased expression of BAX protein]; Chlorogenic Acid inhibits the reaction [Cisplatin results in increased expression of BAX protein]; Chlorogenic Acid inhibits the reaction [sodium arsenite results in increased expression of BAX mRNA] Chlorogenic Acid inhibits the reaction [Methotrexate results in increased expression of BAX protein] Chlorogenic Acid results in increased expression of BAX mRNA; Chlorogenic Acid results in increased expression of BAX protein |
CTD |
PMID:25043994 PMID:28479099 PMID:28623112 PMID:33058431 PMID:33242462 |
|
NCBI chr 1:95,940,001...95,945,407
Ensembl chr 1:95,938,808...95,945,368
|
|
G |
Bcl2 |
BCL2, apoptosis regulator |
multiple interactions decreases expression |
EXP ISO |
Chlorogenic Acid inhibits the reaction [Glucose results in decreased expression of BCL2 protein]; Chlorogenic Acid inhibits the reaction [Methotrexate results in decreased expression of BCL2 protein] Chlorogenic Acid inhibits the reaction [Aluminum Chloride results in decreased expression of BCL2 protein]; Chlorogenic Acid inhibits the reaction [sodium arsenite results in decreased expression of BCL2 mRNA] Chlorogenic Acid results in decreased expression of BCL2 mRNA; Chlorogenic Acid results in decreased expression of BCL2 protein |
CTD |
PMID:28479099 PMID:28623112 PMID:33058431 PMID:33242462 PMID:34801538 |
|
NCBI chr13:22,689,783...22,853,920
Ensembl chr13:22,684,989...22,853,743 Ensembl chr13:22,684,989...22,853,743
|
|
G |
Canx |
calnexin |
multiple interactions |
EXP |
Chlorogenic Acid inhibits the reaction [[Streptozocin co-treated with Dietary Fats co-treated with Fructose] results in increased expression of CANX protein]; Chlorogenic Acid inhibits the reaction [Glucose results in increased expression of CANX protein] |
CTD |
PMID:34801538 |
|
NCBI chr10:34,623,865...34,656,866
Ensembl chr10:34,625,191...34,656,821
|
|
G |
Casp12 |
caspase 12 |
multiple interactions |
EXP |
Chlorogenic Acid inhibits the reaction [Glucose results in increased expression of CASP12 protein] |
CTD |
PMID:34801538 |
|
NCBI chr 8:2,642,296...2,669,549
Ensembl chr 8:2,642,434...2,674,037
|
|
G |
Casp3 |
caspase 3 |
multiple interactions increases expression |
ISO EXP |
Chlorogenic Acid inhibits the reaction [Cisplatin results in increased cleavage of CASP3 protein]; Chlorogenic Acid inhibits the reaction [sodium arsenite results in increased expression of CASP3 mRNA]; Chlorogenic Acid inhibits the reaction [sodium arsenite results in increased expression of CASP3 protein] Chlorogenic Acid inhibits the reaction [Glucose results in increased activity of CASP3 protein]; Chlorogenic Acid inhibits the reaction [Methotrexate results in increased activity of CASP3 protein] Chlorogenic Acid results in increased expression of CASP3 mRNA |
CTD |
PMID:25043994 PMID:28479099 PMID:33058431 PMID:33242462 PMID:34801538 |
|
NCBI chr16:45,662,910...45,681,171
Ensembl chr16:45,662,910...45,684,648
|
|
G |
Casp8 |
caspase 8 |
multiple interactions |
ISO |
Chlorogenic Acid inhibits the reaction [aluminum chloride results in increased expression of CASP8 protein] |
CTD |
PMID:28623112 |
|
NCBI chr 9:60,263,863...60,312,542
Ensembl chr 9:60,264,075...60,312,542
|
|
G |
Casp9 |
caspase 9 |
multiple interactions |
EXP |
Chlorogenic Acid inhibits the reaction [Methotrexate results in increased activity of CASP9 protein] |
CTD |
PMID:28479099 |
|
NCBI chr 5:154,108,872...154,126,628
Ensembl chr 5:154,109,046...154,126,626
|
|
G |
Cat |
catalase |
multiple interactions |
EXP ISO |
Chlorogenic Acid inhibits the reaction [[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased activity of CAT protein]; Chlorogenic Acid inhibits the reaction [Methotrexate results in decreased activity of CAT protein] Chlorogenic Acid inhibits the reaction [Aluminum Chloride results in decreased activity of CAT protein]; Chlorogenic Acid inhibits the reaction [sodium arsenite results in decreased activity of CAT protein]; Chlorogenic Acid inhibits the reaction [sodium arsenite results in decreased expression of CAT mRNA] |
CTD |
PMID:28479099 PMID:28623112 PMID:31390532 PMID:33242462 |
|
NCBI chr 3:89,842,393...89,874,577
Ensembl chr 3:89,842,399...89,874,478
|
|
G |
Ccl2 |
C-C motif chemokine ligand 2 |
multiple interactions |
ISO |
Chlorogenic Acid inhibits the reaction [Acetaminophen results in increased expression of CCL2 mRNA]; Chlorogenic Acid inhibits the reaction [Acetaminophen results in increased secretion of CCL2 protein]; Chlorogenic Acid inhibits the reaction [Lipopolysaccharides results in increased secretion of CCL2 protein] |
CTD |
PMID:26079055 PMID:31306686 |
|
NCBI chr10:67,005,424...67,007,222
Ensembl chr10:67,005,424...67,007,226
|
|
G |
Ccnd1 |
cyclin D1 |
multiple interactions |
ISO |
Chlorogenic Acid inhibits the reaction [Cisplatin results in increased expression of CCND1 protein] |
CTD |
PMID:25043994 |
|
NCBI chr 1:200,089,002...200,098,524
Ensembl chr 1:200,089,002...200,098,602
|
|
G |
Cd44 |
CD44 molecule (Indian blood group) |
increases expression |
ISO |
Chlorogenic Acid results in increased expression of CD44 mRNA |
CTD |
PMID:20706672 |
|
NCBI chr 3:89,155,850...89,244,615
Ensembl chr 3:89,157,058...89,244,620
|
|
G |
Cdh1 |
cadherin 1 |
increases expression |
ISO |
Chlorogenic Acid results in increased expression of CDH1 mRNA |
CTD |
PMID:20706672 |
|
NCBI chr19:34,492,371...34,561,775
Ensembl chr19:34,492,371...34,561,775
|
|
G |
Col1a1 |
collagen type I alpha 1 chain |
increases expression multiple interactions |
ISO EXP |
Chlorogenic Acid results in increased expression of COL1A1 mRNA Chlorogenic Acid inhibits the reaction [Carbon Tetrachloride results in increased expression of COL1A1 mRNA] |
CTD |
PMID:20706672 PMID:23146752 |
|
NCBI chr10:79,883,622...79,900,625
Ensembl chr10:79,883,622...79,900,624
|
|
G |
Col2a1 |
collagen type II alpha 1 chain |
multiple interactions |
EXP |
[geniposide co-treated with phellodendrine co-treated with magnoflorine co-treated with Chlorogenic Acid co-treated with crocin co-treated with Flavonoids co-treated with Berberine Alkaloids] inhibits the reaction [[COL2A1 protein co-treated with Freund's Adjuvant] results in decreased abundance of Amino Acids]; [geniposide co-treated with phellodendrine co-treated with magnoflorine co-treated with Chlorogenic Acid co-treated with crocin co-treated with Flavonoids co-treated with Berberine Alkaloids] inhibits the reaction [[COL2A1 protein co-treated with Freund's Adjuvant] results in decreased abundance of Pantothenic Acid]; [geniposide co-treated with phellodendrine co-treated with magnoflorine co-treated with Chlorogenic Acid co-treated with crocin co-treated with Flavonoids co-treated with Berberine Alkaloids] inhibits the reaction [[COL2A1 protein co-treated with Freund's Adjuvant] results in decreased abundance of phenylpyruvic acid]; [geniposide co-treated with phellodendrine co-treated with magnoflorine co-treated with Chlorogenic Acid co-treated with crocin co-treated with Flavonoids co-treated with Berberine Alkaloids] inhibits the reaction [[COL2A1 protein co-treated with Freund's Adjuvant] results in increased abundance of Allantoin]; [geniposide co-treated with phellodendrine co-treated with magnoflorine co-treated with Chlorogenic Acid co-treated with crocin co-treated with Flavonoids co-treated with Berberine Alkaloids] inhibits the reaction [[COL2A1 protein co-treated with Freund's Adjuvant] results in increased abundance of Amino Acids]; [geniposide co-treated with phellodendrine co-treated with magnoflorine co-treated with Chlorogenic Acid co-treated with crocin co-treated with Flavonoids co-treated with Berberine Alkaloids] inhibits the reaction [[COL2A1 protein co-treated with Freund's Adjuvant] results in increased abundance of Carnitine]; [geniposide co-treated with phellodendrine co-treated with magnoflorine co-treated with Chlorogenic Acid co-treated with crocin co-treated with Flavonoids co-treated with Berberine Alkaloids] inhibits the reaction [[COL2A1 protein co-treated with Freund's Adjuvant] results in increased abundance of Citric Acid]; [geniposide co-treated with phellodendrine co-treated with magnoflorine co-treated with Chlorogenic Acid co-treated with crocin co-treated with Flavonoids co-treated with Berberine Alkaloids] inhibits the reaction [[COL2A1 protein co-treated with Freund's Adjuvant] results in increased abundance of Creatine]; [geniposide co-treated with phellodendrine co-treated with magnoflorine co-treated with Chlorogenic Acid co-treated with crocin co-treated with Flavonoids co-treated with Berberine Alkaloids] inhibits the reaction [[COL2A1 protein co-treated with Freund's Adjuvant] results in increased abundance of Creatinine]; [geniposide co-treated with phellodendrine co-treated with magnoflorine co-treated with Chlorogenic Acid co-treated with crocin co-treated with Flavonoids co-treated with Berberine Alkaloids] inhibits the reaction [[COL2A1 protein co-treated with Freund's Adjuvant] results in increased abundance of phenylacetylglycine]; [geniposide co-treated with phellodendrine co-treated with magnoflorine co-treated with Chlorogenic Acid co-treated with crocin co-treated with Flavonoids co-treated with Berberine Alkaloids] inhibits the reaction [[COL2A1 protein co-treated with Freund's Adjuvant] results in increased abundance of Succinic Acid]; [geniposide co-treated with phellodendrine co-treated with magnoflorine co-treated with Chlorogenic Acid co-treated with crocin co-treated with Flavonoids co-treated with Berberine Alkaloids] inhibits the reaction [[COL2A1 protein co-treated with Freund's Adjuvant] results in increased abundance of Uric Acid]; [geniposide co-treated with phellodendrine co-treated with magnoflorine co-treated with Chlorogenic Acid co-treated with crocin co-treated with Flavonoids co-treated with Berberine Alkaloids] inhibits the reaction [[COL2A1 protein co-treated with Freund's Adjuvant] results in increased abundance of Uridine]; [geniposide co-treated with phellodendrine co-treated with magnoflorine co-treated with Chlorogenic Acid co-treated with crocin co-treated with Flavonoids co-treated with Berberine Alkaloids] inhibits the reaction [[COL2A1 protein co-treated with Freund's Adjuvant] results in increased secretion of IL1B protein] |
CTD |
PMID:24709313 |
|
NCBI chr 7:129,098,489...129,127,560
Ensembl chr 7:129,098,786...129,127,546
|
|
G |
Cs |
citrate synthase |
increases activity |
ISO |
Chlorogenic Acid results in increased activity of CS protein |
CTD |
PMID:31306686 |
|
NCBI chr 7:758,074...791,421
Ensembl chr 7:758,345...791,421
|
|
G |
Cxcl3 |
C-X-C motif chemokine ligand 3 |
multiple interactions |
ISO |
Chlorogenic Acid inhibits the reaction [Acetaminophen results in increased expression of CXCL1 mRNA]; Chlorogenic Acid inhibits the reaction [Acetaminophen results in increased secretion of CXCL1 protein] |
CTD |
PMID:26079055 |
|
NCBI chr14:17,287,727...17,289,451
Ensembl chr14:17,270,146...17,289,511
|
|
G |
Cygb |
cytoglobin |
decreases expression |
ISO |
Chlorogenic Acid results in decreased expression of CYGB mRNA |
CTD |
PMID:20706672 |
|
NCBI chr10:101,877,675...101,887,442
Ensembl chr10:101,877,676...101,887,442
|
|
G |
Cyp19a1 |
cytochrome P450, family 19, subfamily a, polypeptide 1 |
increases expression |
EXP |
Chlorogenic Acid results in increased expression of CYP19A1 protein |
CTD |
PMID:29899696 |
|
NCBI chr 8:54,552,978...54,580,375
Ensembl chr 8:54,553,165...54,580,758
|
|
G |
Cyp2e1 |
cytochrome P450, family 2, subfamily e, polypeptide 1 |
multiple interactions |
ISO |
Chlorogenic Acid inhibits the reaction [Cisplatin results in increased expression of CYP2E1 protein] |
CTD |
PMID:25043994 |
|
NCBI chr 1:195,840,330...195,850,728
Ensembl chr 1:195,840,058...195,864,023
|
|
G |
Ddit3 |
DNA-damage inducible transcript 3 |
multiple interactions |
EXP |
Chlorogenic Acid inhibits the reaction [[Streptozocin co-treated with Dietary Fats co-treated with Fructose] results in increased expression of DDIT3 protein]; Chlorogenic Acid inhibits the reaction [Glucose results in increased expression of DDIT3 protein] |
CTD |
PMID:34801538 |
|
NCBI chr 7:63,115,645...63,121,203
Ensembl chr 7:63,116,380...63,121,201
|
|
G |
Dsg3 |
desmoglein 3 |
decreases expression |
ISO |
Chlorogenic Acid results in decreased expression of DSG3 mRNA |
CTD |
PMID:20706672 |
|
NCBI chr18:11,799,355...11,830,988
Ensembl chr18:11,798,900...11,830,818
|
|
G |
Egf |
epidermal growth factor |
decreases expression |
ISO |
Chlorogenic Acid results in decreased expression of EGF mRNA |
CTD |
PMID:20706672 |
|
NCBI chr 2:218,219,408...218,302,359
Ensembl chr 2:218,219,415...218,302,064
|
|
G |
Eif2ak3 |
eukaryotic translation initiation factor 2 alpha kinase 3 |
multiple interactions |
EXP |
Chlorogenic Acid inhibits the reaction [[Streptozocin co-treated with Dietary Fats co-treated with Fructose] results in increased expression of EIF2AK3 protein]; Chlorogenic Acid inhibits the reaction [Glucose results in increased phosphorylation of EIF2AK3 protein] |
CTD |
PMID:34801538 |
|
NCBI chr 4:102,805,495...102,866,914
Ensembl chr 4:102,805,510...102,866,911
|
|
G |
Eif2s1 |
eukaryotic translation initiation factor 2 subunit alpha |
multiple interactions |
EXP |
Chlorogenic Acid inhibits the reaction [Glucose results in increased phosphorylation of EIF2S1 protein] |
CTD |
PMID:34801538 |
|
NCBI chr 6:97,672,829...97,697,499
Ensembl chr 6:97,672,766...97,706,225
|
|
G |
Ern1 |
endoplasmic reticulum to nucleus signaling 1 |
multiple interactions |
EXP |
Chlorogenic Acid inhibits the reaction [[Streptozocin co-treated with Dietary Fats co-treated with Fructose] results in increased expression of ERN1 protein]; Chlorogenic Acid inhibits the reaction [Glucose results in increased phosphorylation of ERN1 protein] |
CTD |
PMID:34801538 |
|
NCBI chr10:91,326,889...91,421,201
Ensembl chr10:91,330,654...91,421,029
|
|
G |
Ero1a |
endoplasmic reticulum oxidoreductase 1 alpha |
multiple interactions |
EXP |
Chlorogenic Acid inhibits the reaction [Glucose results in increased expression of ERO1A protein] |
CTD |
PMID:34801538 |
|
NCBI chr15:18,495,037...18,530,440
Ensembl chr15:18,492,945...18,530,478
|
|
G |
Esr1 |
estrogen receptor 1 |
decreases expression |
EXP |
Chlorogenic Acid results in decreased expression of ESR1 protein |
CTD |
PMID:29899696 |
|
NCBI chr 1:41,106,335...41,499,104
Ensembl chr 1:41,210,475...41,495,002
|
|
G |
Esr2 |
estrogen receptor 2 |
increases expression |
EXP |
Chlorogenic Acid results in increased expression of ESR2 protein |
CTD |
PMID:29899696 |
|
NCBI chr 6:94,858,438...94,909,630
Ensembl chr 6:94,809,547...94,908,919
|
|
G |
F10 |
coagulation factor X |
decreases activity |
ISO |
Chlorogenic Acid results in decreased activity of F10 protein |
CTD |
PMID:27704645 |
|
NCBI chr16:76,468,834...76,488,141
Ensembl chr16:76,468,838...76,488,141
|
|
G |
F2 |
coagulation factor II, thrombin |
decreases activity |
ISO |
Chlorogenic Acid results in decreased activity of F2 protein |
CTD |
PMID:27704645 |
|
NCBI chr 3:77,596,196...77,609,486
Ensembl chr 3:77,596,198...77,609,486
|
|
G |
Fasn |
fatty acid synthase |
decreases expression |
ISO |
Chlorogenic Acid results in decreased expression of FASN mRNA |
CTD |
PMID:21870829 |
|
NCBI chr10:106,072,093...106,090,259
Ensembl chr10:106,072,091...106,090,261
|
|
G |
Fbn1 |
fibrillin 1 |
decreases expression |
ISO |
Chlorogenic Acid results in decreased expression of FBN1 mRNA |
CTD |
PMID:20706672 |
|
NCBI chr 3:112,554,257...112,750,835
Ensembl chr 3:112,554,925...112,750,889
|
|
G |
Fbn2 |
fibrillin 2 |
decreases expression |
ISO |
Chlorogenic Acid results in decreased expression of FBN2 mRNA |
CTD |
PMID:20706672 |
|
NCBI chr18:51,499,670...51,703,976
Ensembl chr18:51,499,737...51,703,976
|
|
G |
Ffar1 |
free fatty acid receptor 1 |
multiple interactions |
ISO |
Chlorogenic Acid inhibits the reaction [Rotenone results in decreased expression of FFAR1 mRNA] |
CTD |
PMID:36048341 |
|
NCBI chr 1:86,111,368...86,112,272
Ensembl chr 1:86,111,368...86,112,272
|
|
G |
Ffar2 |
free fatty acid receptor 2 |
multiple interactions |
ISO |
Chlorogenic Acid inhibits the reaction [Rotenone results in decreased expression of FFAR2 mRNA] |
CTD |
PMID:36048341 |
|
NCBI chr 1:86,071,855...86,075,049
Ensembl chr 1:86,072,184...86,075,033
|
|
G |
Fgf1 |
fibroblast growth factor 1 |
increases expression |
ISO |
Chlorogenic Acid results in increased expression of FGF1 mRNA |
CTD |
PMID:20706672 |
|
NCBI chr18:30,686,555...30,772,667
Ensembl chr18:30,686,581...30,772,357
|
|
G |
Fshb |
follicle stimulating hormone subunit beta |
multiple interactions |
ISO |
Chlorogenic Acid inhibits the reaction [sodium arsenite results in decreased expression of FSHB protein] |
CTD |
PMID:33242462 |
|
NCBI chr 3:93,548,560...93,552,370
Ensembl chr 3:93,548,560...93,552,370
|
|
G |
Fshr |
follicle stimulating hormone receptor |
increases expression |
EXP |
Chlorogenic Acid results in increased expression of FSHR protein |
CTD |
PMID:29899696 |
|
NCBI chr 6:5,198,825...5,406,785
Ensembl chr 6:5,198,825...5,406,785
|
|
G |
Gcg |
glucagon |
multiple interactions |
ISO |
[Chlorogenic Acid co-treated with Rotenone] results in increased secretion of GCG protein |
CTD |
PMID:36048341 |
|
NCBI chr 3:47,113,914...47,122,958
Ensembl chr 3:47,113,914...47,122,929
|
|
G |
Gclc |
glutamate-cysteine ligase, catalytic subunit |
increases expression multiple interactions |
ISO |
Chlorogenic Acid results in increased expression of GCLC mRNA Chlorogenic Acid promotes the reaction [Acetaminophen results in increased expression of GCLC mRNA] |
CTD |
PMID:29136249 |
|
NCBI chr 8:78,629,899...78,668,547
Ensembl chr 8:78,630,127...78,668,544
|
|
G |
Gclm |
glutamate cysteine ligase, modifier subunit |
increases expression |
ISO |
Chlorogenic Acid results in increased expression of GCLM mRNA |
CTD |
PMID:29136249 |
|
NCBI chr 2:210,347,482...210,367,537
Ensembl chr 2:210,347,482...210,367,535
|
|
G |
Glp1r |
glucagon-like peptide 1 receptor |
multiple interactions |
ISO |
Chlorogenic Acid inhibits the reaction [Rotenone results in decreased expression of GLP1R protein] |
CTD |
PMID:36048341 |
|
NCBI chr20:8,972,004...9,010,241
Ensembl chr20:8,972,004...9,010,241
|
|
G |
Gpt |
glutamic--pyruvic transaminase |
multiple interactions decreases expression |
EXP ISO |
Chlorogenic Acid inhibits the reaction [[Cadmium Chloride results in increased abundance of Cadmium] which results in increased activity of GPT protein]; Chlorogenic Acid inhibits the reaction [Methotrexate results in increased activity of GPT protein] Chlorogenic Acid results in decreased expression of GPT protein Chlorogenic Acid inhibits the reaction [aluminum chloride results in increased activity of GPT protein] |
CTD |
PMID:28479099 PMID:28623112 PMID:31390532 PMID:33058431 |
|
NCBI chr 7:108,416,646...108,419,495
Ensembl chr 7:108,416,642...108,419,494
|
|
G |
Gpx1 |
glutathione peroxidase 1 |
multiple interactions |
ISO |
Chlorogenic Acid inhibits the reaction [sodium arsenite results in decreased expression of GPX1 mRNA] |
CTD |
PMID:33242462 |
|
NCBI chr 8:109,026,905...109,028,031
Ensembl chr 8:109,026,905...109,028,024
|
|
G |
Grn |
granulin precursor |
increases expression |
ISO |
Chlorogenic Acid results in increased expression of GRN mRNA |
CTD |
PMID:20706672 |
|
NCBI chr10:87,387,672...87,393,777
Ensembl chr10:87,387,638...87,393,775
|
|
G |
Gsk3b |
glycogen synthase kinase 3 beta |
multiple interactions |
ISO |
Chlorogenic Acid inhibits the reaction [Rotenone results in decreased phosphorylation of GSK3B protein] |
CTD |
PMID:36048341 |
|
NCBI chr11:62,498,997...62,648,665
Ensembl chr11:62,504,316...62,648,646
|
|
G |
Gsr |
glutathione-disulfide reductase |
multiple interactions |
EXP ISO |
Chlorogenic Acid inhibits the reaction [Methotrexate results in decreased activity of GSR protein] Chlorogenic Acid inhibits the reaction [sodium arsenite results in decreased activity of GSR protein]; Chlorogenic Acid inhibits the reaction [sodium arsenite results in decreased expression of GSR mRNA] |
CTD |
PMID:28479099 PMID:33242462 |
|
NCBI chr16:58,482,209...58,525,256
Ensembl chr16:58,482,505...58,525,661
|
|
G |
Gsta2 |
glutathione S-transferase alpha 2 |
increases activity |
ISO |
Chlorogenic Acid results in increased activity of GSTA1 protein |
CTD |
PMID:15944151 |
|
NCBI chr 8:79,184,535...79,196,827
Ensembl chr 8:79,184,322...79,196,798
|
|
G |
Has1 |
hyaluronan synthase 1 |
increases expression |
ISO |
Chlorogenic Acid results in increased expression of HAS1 mRNA |
CTD |
PMID:20706672 |
|
NCBI chr 1:58,693,411...58,705,653
Ensembl chr 1:58,693,411...58,705,397
|
|
G |
Hlcs |
holocarboxylase synthetase |
decreases activity |
ISO |
Chlorogenic Acid results in decreased activity of HLCS protein |
CTD |
PMID:26303405 |
|
NCBI chr11:33,455,806...33,635,197
Ensembl chr11:33,455,809...33,624,222
|
|
G |
Hmgcr |
3-hydroxy-3-methylglutaryl-CoA reductase |
multiple interactions decreases expression |
EXP ISO |
[tetrahydrocurcumin co-treated with Chlorogenic Acid] results in decreased susceptibility to [[Streptozocin co-treated with Niacinamide] results in increased activity of HMGCR protein]; Chlorogenic Acid results in decreased susceptibility to [[Streptozocin co-treated with Niacinamide] results in increased activity of HMGCR protein] Chlorogenic Acid results in decreased expression of HMGCR mRNA |
CTD |
PMID:20696151 PMID:21870829 |
|
NCBI chr 2:27,997,523...28,018,983
Ensembl chr 2:27,997,525...28,019,703
|
|
G |
Hmox1 |
heme oxygenase 1 |
multiple interactions increases expression |
ISO |
Chlorogenic Acid inhibits the reaction [Cisplatin results in increased expression of HMOX1 protein] Chlorogenic Acid results in increased expression of HMOX1 mRNA Chlorogenic Acid inhibits the reaction [Acetaminophen results in decreased expression of HMOX1 mRNA]; Chlorogenic Acid inhibits the reaction [Acetaminophen results in decreased expression of HMOX1 protein] |
CTD |
PMID:25043994 PMID:29136249 |
|
NCBI chr19:13,466,287...13,474,082
Ensembl chr19:13,467,244...13,474,079
|
|
G |
Hspa5 |
heat shock protein family A (Hsp70) member 5 |
multiple interactions |
EXP |
Chlorogenic Acid inhibits the reaction [[Streptozocin co-treated with Dietary Fats co-treated with Fructose] results in increased expression of HSPA5 protein]; Chlorogenic Acid inhibits the reaction [Glucose results in increased expression of HSPA5 protein] |
CTD |
PMID:34801538 |
|
NCBI chr 3:18,055,507...18,059,969
Ensembl chr 3:18,055,405...18,059,891
|
|
G |
Hspb1 |
heat shock protein family B (small) member 1 |
increases expression |
ISO |
Chlorogenic Acid results in increased expression of HSPB1 mRNA |
CTD |
PMID:20706672 |
|
NCBI chr12:20,794,014...20,795,675
Ensembl chr12:20,794,028...20,795,743
|
|
G |
Il1a |
interleukin 1 alpha |
decreases expression |
ISO |
Chlorogenic Acid results in decreased expression of IL1A mRNA |
CTD |
PMID:20706672 |
|
NCBI chr 3:116,526,601...116,537,055
Ensembl chr 3:116,526,604...116,536,822
|
|
G |
Il1b |
interleukin 1 beta |
multiple interactions |
EXP ISO |
[geniposide co-treated with phellodendrine co-treated with magnoflorine co-treated with Chlorogenic Acid co-treated with crocin co-treated with Flavonoids co-treated with Berberine Alkaloids] inhibits the reaction [[COL2A1 protein co-treated with Freund's Adjuvant] results in increased secretion of IL1B protein]; Chlorogenic Acid inhibits the reaction [Carbon Tetrachloride results in increased expression of IL1B mRNA] Chlorogenic Acid inhibits the reaction [Acetaminophen results in increased expression of IL1B mRNA]; Chlorogenic Acid inhibits the reaction [Acetaminophen results in increased secretion of IL1B protein]; Chlorogenic Acid inhibits the reaction [sodium arsenite results in increased expression of IL1B protein] |
CTD |
PMID:23146752 PMID:24709313 PMID:26079055 PMID:33242462 |
|
NCBI chr 3:116,577,005...116,583,386
Ensembl chr 3:116,577,010...116,583,415
|
|
G |
Il6 |
interleukin 6 |
increases expression multiple interactions |
ISO EXP |
Chlorogenic Acid results in increased expression of IL6 mRNA Chlorogenic Acid inhibits the reaction [Acetaminophen results in increased expression of IL6 mRNA]; Chlorogenic Acid inhibits the reaction [Acetaminophen results in increased secretion of IL6 protein]; Chlorogenic Acid inhibits the reaction [sodium arsenite results in increased expression of IL6 protein] Chlorogenic Acid inhibits the reaction [[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of IL6 protein]; Chlorogenic Acid inhibits the reaction [Carbon Tetrachloride results in increased expression of IL6 mRNA] |
CTD |
PMID:21870829 PMID:23146752 PMID:26079055 PMID:31390532 PMID:33242462 |
|
NCBI chr 4:5,214,602...5,219,178
Ensembl chr 4:5,213,394...5,219,178
|
|
G |
Itgb2 |
integrin subunit beta 2 |
decreases expression multiple interactions |
EXP |
Chlorogenic Acid results in decreased expression of ITGB2 protein Chlorogenic Acid inhibits the reaction [lipopolysaccharide, E. coli O26-B6 results in increased expression of ITGB2 protein] |
CTD |
PMID:21414398 |
|
NCBI chr20:11,061,394...11,097,656
Ensembl chr20:11,061,430...11,097,600
|
|
G |
Jun |
Jun proto-oncogene, AP-1 transcription factor subunit |
multiple interactions |
ISO |
Chlorogenic Acid inhibits the reaction [Tetradecanoylphorbol Acetate results in increased activity of JUN protein] |
CTD |
PMID:15944151 |
|
NCBI chr 5:109,894,175...109,897,268
Ensembl chr 5:109,893,145...109,897,656
|
|
G |
Krt5 |
keratin 5 |
increases expression |
ISO |
Chlorogenic Acid results in increased expression of KRT5 mRNA |
CTD |
PMID:20706672 |
|
NCBI chr 7:132,846,132...132,851,861
Ensembl chr 7:132,846,136...132,851,850
|
|
G |
Lcat |
lecithin cholesterol acyltransferase |
multiple interactions |
EXP |
[tetrahydrocurcumin co-treated with Chlorogenic Acid] results in decreased susceptibility to [[Streptozocin co-treated with Niacinamide] results in decreased activity of LCAT protein]; Chlorogenic Acid results in decreased susceptibility to [[Streptozocin co-treated with Niacinamide] results in decreased activity of LCAT protein] |
CTD |
PMID:20696151 |
|
NCBI chr19:33,834,748...33,838,214
Ensembl chr19:33,834,403...33,838,231
|
|
G |
Lhb |
luteinizing hormone subunit beta |
multiple interactions |
ISO |
Chlorogenic Acid inhibits the reaction [sodium arsenite results in decreased expression of LHB protein] |
CTD |
PMID:33242462 |
|
NCBI chr 1:95,898,269...95,901,973
Ensembl chr 1:95,900,984...95,901,972 Ensembl chr 1:95,900,984...95,901,972
|
|
G |
Lpl |
lipoprotein lipase |
multiple interactions |
EXP |
[tetrahydrocurcumin co-treated with Chlorogenic Acid] results in decreased susceptibility to [[Streptozocin co-treated with Niacinamide] results in decreased activity of LPL protein]; Chlorogenic Acid results in decreased susceptibility to [[Streptozocin co-treated with Niacinamide] results in decreased activity of LPL protein] |
CTD |
PMID:20696151 |
|
NCBI chr16:20,830,055...20,853,855
Ensembl chr16:20,829,465...20,855,249
|
|
G |
Maoa |
monoamine oxidase A |
decreases activity |
ISO |
Chlorogenic Acid results in decreased activity of MAOA protein |
CTD |
PMID:27270453 |
|
NCBI chr X:6,032,172...6,098,308
Ensembl chr X:6,030,795...6,099,593
|
|
G |
Maob |
monoamine oxidase B |
decreases activity |
ISO |
Chlorogenic Acid results in decreased activity of MAOB protein |
CTD |
PMID:27270453 |
|
NCBI chr X:5,907,327...6,010,996
Ensembl chr X:5,907,266...6,011,003
|
|
G |
Map2k4 |
mitogen activated protein kinase kinase 4 |
multiple interactions |
ISO |
Chlorogenic Acid inhibits the reaction [Tetradecanoylphorbol Acetate results in increased phosphorylation of MAP2K4 protein] |
CTD |
PMID:15944151 |
|
NCBI chr10:50,343,227...50,447,956
Ensembl chr10:50,344,915...50,447,993
|
|
G |
Mapk1 |
mitogen activated protein kinase 1 |
multiple interactions |
ISO |
Chlorogenic Acid inhibits the reaction [Tetradecanoylphorbol Acetate results in increased phosphorylation of MAPK1 protein] Chlorogenic Acid promotes the reaction [Acetaminophen results in increased phosphorylation of MAPK1 protein] |
CTD |
PMID:15944151 PMID:29136249 |
|
NCBI chr11:83,957,813...84,023,629
Ensembl chr11:83,957,813...84,023,616
|
|
G |
Mapk14 |
mitogen activated protein kinase 14 |
multiple interactions |
ISO |
Chlorogenic Acid inhibits the reaction [Tetradecanoylphorbol Acetate results in increased phosphorylation of MAPK14 protein] |
CTD |
PMID:15944151 |
|
NCBI chr20:6,749,646...6,810,590
Ensembl chr20:6,749,670...6,810,589
|
|
G |
Mapk3 |
mitogen activated protein kinase 3 |
multiple interactions |
ISO |
Chlorogenic Acid inhibits the reaction [Tetradecanoylphorbol Acetate results in increased phosphorylation of MAPK3 protein] Chlorogenic Acid promotes the reaction [Acetaminophen results in increased phosphorylation of MAPK3 protein] |
CTD |
PMID:15944151 PMID:29136249 |
|
NCBI chr 1:181,366,646...181,372,863
Ensembl chr 1:181,366,637...181,372,863
|
|
G |
Mapk8 |
mitogen-activated protein kinase 8 |
multiple interactions |
EXP |
Chlorogenic Acid inhibits the reaction [Glucose results in increased phosphorylation of MAPK8 protein] |
CTD |
PMID:34801538 |
|
NCBI chr16:8,638,897...8,721,960
Ensembl chr16:8,638,924...8,721,981
|
|
G |
Mc1r |
melanocortin 1 receptor |
increases expression |
ISO |
Chlorogenic Acid results in increased expression of MC1R mRNA |
CTD |
PMID:20706672 |
|
NCBI chr19:51,452,448...51,455,375
Ensembl chr19:51,453,239...51,454,192
|
|
G |
Mgst1 |
microsomal glutathione S-transferase 1 |
decreases activity |
EXP |
Chlorogenic Acid results in decreased activity of MGST1 protein |
CTD |
PMID:16125204 |
|
NCBI chr 4:171,029,666...171,044,893
Ensembl chr 4:171,029,630...171,044,892
|
|
G |
Mpo |
myeloperoxidase |
multiple interactions |
ISO |
Chlorogenic Acid inhibits the reaction [Acetaminophen results in increased expression of MPO protein] |
CTD |
PMID:26079055 |
|
NCBI chr10:72,594,883...72,608,862
Ensembl chr10:72,594,661...72,604,819
|
|
G |
Mt-co1 |
mitochondrially encoded cytochrome c oxidase I |
increases expression |
ISO |
Chlorogenic Acid results in increased expression of COX1 mRNA |
CTD |
PMID:20706672 |
|
NCBI chr MT:5,323...6,867
Ensembl chr MT:5,323...6,867
|
|
G |
Mt-co2 |
mitochondrially encoded cytochrome c oxidase II |
multiple interactions |
ISO |
[Chlorogenic Acid co-treated with Zymosan] results in decreased expression of COX2 protein; Chlorogenic Acid inhibits the reaction [Zymosan results in increased expression of COX2 protein] |
CTD |
PMID:30481570 |
|
NCBI chr MT:7,006...7,689
Ensembl chr MT:7,006...7,689
|
|
G |
Myd88 |
MYD88, innate immune signal transduction adaptor |
multiple interactions |
EXP ISO |
Chlorogenic Acid inhibits the reaction [Carbon Tetrachloride results in increased expression of MYD88 mRNA]; Chlorogenic Acid inhibits the reaction [Carbon Tetrachloride results in increased expression of MYD88 protein] Chlorogenic Acid inhibits the reaction [Acetaminophen results in increased expression of MYD88 protein] |
CTD |
PMID:23146752 PMID:26079055 |
|
NCBI chr 8:119,074,439...119,078,508
Ensembl chr 8:119,074,437...119,079,415
|
|
G |
Nfe2l2 |
NFE2 like bZIP transcription factor 2 |
increases localization multiple interactions increases response to substance affects localization decreases response to substance |
ISO |
Chlorogenic Acid results in increased localization of NFE2L2 protein 2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [[Chlorogenic Acid co-treated with Acetaminophen] results in increased phosphorylation of and affects the localization of and results in increased activity of NFE2L2 protein]; [Chlorogenic Acid co-treated with Acetaminophen] results in increased activity of and affects the localization of NFE2L2 protein; [Chlorogenic Acid co-treated with Acetaminophen] results in increased phosphorylation of and affects the localization of and results in increased activity of NFE2L2 protein; U 0126 inhibits the reaction [[Chlorogenic Acid co-treated with Acetaminophen] results in increased phosphorylation of and affects the localization of and results in increased activity of NFE2L2 protein] [Chlorogenic Acid co-treated with Acetaminophen] affects the localization of and results in increased activity of NFE2L2 protein; Chlorogenic Acid inhibits the reaction [sodium arsenite results in decreased expression of NFE2L2 mRNA] NFE2L2 results in increased susceptibility to Chlorogenic Acid Chlorogenic Acid affects the localization of NFE2L2 protein NFE2L2 gene mutant form results in decreased susceptibility to Chlorogenic Acid |
CTD |
PMID:15944151 PMID:29136249 PMID:33242462 |
|
NCBI chr 3:60,594,239...60,621,712
Ensembl chr 3:60,594,242...60,621,737
|
|
G |
Nfkbia |
NFKB inhibitor alpha |
multiple interactions |
ISO EXP |
Chlorogenic Acid inhibits the reaction [Tetradecanoylphorbol Acetate results in increased degradation of NFKBIA protein] Chlorogenic Acid inhibits the reaction [Carbon Tetrachloride results in decreased expression of and results in increased phosphorylation of NFKBIA protein] |
CTD |
PMID:20026373 PMID:23146752 |
|
NCBI chr 6:72,858,713...72,861,941
Ensembl chr 6:72,858,712...72,861,941
|
|
G |
Nfkbib |
NFKB inhibitor beta |
multiple interactions |
ISO |
Chlorogenic Acid inhibits the reaction [Tetradecanoylphorbol Acetate results in increased phosphorylation of and results in increased activity of NFKBIB protein] |
CTD |
PMID:20026373 |
|
NCBI chr 1:84,046,292...84,053,862
Ensembl chr 1:84,046,295...84,053,862
|
|
G |
Nos2 |
nitric oxide synthase 2 |
multiple interactions |
ISO EXP |
Chlorogenic Acid inhibits the reaction [[Tetradecanoylphorbol Acetate results in increased expression of NOS2 protein] which results in increased abundance of Nitrites]; Chlorogenic Acid inhibits the reaction [Lipopolysaccharides results in increased expression of NOS2 protein]; Chlorogenic Acid inhibits the reaction [sodium arsenite results in increased expression of NOS2 mRNA]; Chlorogenic Acid inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of NOS2 protein] Chlorogenic Acid inhibits the reaction [Carbon Tetrachloride results in increased expression of NOS2 mRNA]; Chlorogenic Acid inhibits the reaction [Carbon Tetrachloride results in increased expression of NOS2 protein]; Chlorogenic Acid inhibits the reaction [Methotrexate results in increased expression of NOS2 protein] |
CTD |
PMID:20026373 PMID:23146752 PMID:28479099 PMID:31306686 PMID:33242462 |
|
NCBI chr10:63,815,308...63,851,208
Ensembl chr10:63,815,308...63,851,210
|
|
G |
Nos3 |
nitric oxide synthase 3 |
increases expression |
ISO |
Chlorogenic Acid results in increased expression of NOS3 mRNA |
CTD |
PMID:20706672 |
|
NCBI chr 4:10,793,834...10,814,170
Ensembl chr 4:10,793,834...10,814,166
|
|
G |
Nppb |
natriuretic peptide B |
multiple interactions |
EXP |
Chlorogenic Acid inhibits the reaction [[Streptozocin co-treated with Dietary Fats co-treated with Fructose] results in increased expression of NPPB protein] |
CTD |
PMID:34801538 |
|
NCBI chr 5:158,416,813...158,418,175
Ensembl chr 5:158,416,866...158,418,168
|
|
G |
Nqo1 |
NAD(P)H quinone dehydrogenase 1 |
increases activity increases expression multiple interactions |
ISO |
Chlorogenic Acid results in increased activity of NQO1 protein Chlorogenic Acid results in increased expression of NQO1 mRNA Chlorogenic Acid inhibits the reaction [Acetaminophen results in decreased expression of NQO1 mRNA]; Chlorogenic Acid inhibits the reaction [Acetaminophen results in decreased expression of NQO1 protein] |
CTD |
PMID:15944151 PMID:29136249 |
|
NCBI chr19:35,295,633...35,310,528
Ensembl chr19:35,295,573...35,310,557
|
|
G |
Ocln |
occludin |
multiple interactions |
EXP |
Chlorogenic Acid inhibits the reaction [[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of OCLN mRNA]; Chlorogenic Acid inhibits the reaction [[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of OCLN protein] |
CTD |
PMID:31390532 |
|
NCBI chr 2:31,657,217...31,707,466
Ensembl chr 2:31,657,220...31,764,150
|
|
G |
P4hb |
prolyl 4-hydroxylase subunit beta |
multiple interactions |
EXP |
Chlorogenic Acid inhibits the reaction [Glucose results in increased expression of P4HB protein] |
CTD |
PMID:34801538 |
|
NCBI chr10:105,836,972...105,848,583
Ensembl chr10:105,836,982...105,848,500
|
|
G |
Pcna |
proliferating cell nuclear antigen |
multiple interactions |
ISO |
Chlorogenic Acid promotes the reaction [Cisplatin results in increased expression of PCNA protein] |
CTD |
PMID:25043994 |
|
NCBI chr 3:119,499,039...119,502,911
Ensembl chr 3:119,498,810...119,502,995
|
|
G |
Pecam1 |
platelet and endothelial cell adhesion molecule 1 |
multiple interactions |
EXP |
Chlorogenic Acid inhibits the reaction [lipopolysaccharide, E. coli O26-B6 results in increased expression of PECAM1 protein] |
CTD |
PMID:21414398 |
|
NCBI chr10:91,590,521...91,652,279
Ensembl chr10:91,590,521...91,652,116
|
|
G |
Pgr |
progesterone receptor |
increases expression decreases expression |
ISO |
Chlorogenic Acid results in increased expression of PGR mRNA Chlorogenic Acid results in decreased expression of PGR mRNA |
CTD |
PMID:20706672 |
|
NCBI chr 8:6,072,673...6,131,552
Ensembl chr 8:6,072,673...6,131,344
|
|
G |
Pik3r1 |
phosphoinositide-3-kinase regulatory subunit 1 |
increases expression multiple interactions |
ISO |
Chlorogenic Acid results in increased expression of PIK3R1 mRNA Chlorogenic Acid inhibits the reaction [Rotenone results in decreased phosphorylation of PIK3R1 protein] |
CTD |
PMID:21870829 PMID:36048341 |
|
NCBI chr 2:32,878,942...32,963,668
Ensembl chr 2:32,882,032...32,963,631
|
|
G |
Plod3 |
procollagen-lysine, 2-oxoglutarate 5-dioxygenase 3 |
increases expression |
ISO |
Chlorogenic Acid results in increased expression of PLOD3 mRNA |
CTD |
PMID:20706672 |
|
NCBI chr12:19,676,384...19,686,945
Ensembl chr12:19,676,386...19,686,960
|
|
G |
Pparg |
peroxisome proliferator-activated receptor gamma |
increases expression decreases expression |
ISO |
Chlorogenic Acid results in increased expression of PPARG mRNA Chlorogenic Acid results in decreased expression of PPARG mRNA |
CTD |
PMID:20706672 PMID:21870829 |
|
NCBI chr 4:148,423,102...148,548,471
Ensembl chr 4:148,423,194...148,548,468
|
|
G |
Ppp2r1a |
protein phosphatase 2 scaffold subunit A alpha |
multiple interactions |
ISO |
[Chlorogenic Acid co-treated with Acetaminophen] results in decreased expression of PPP2R1A protein |
CTD |
PMID:29136249 |
|
NCBI chr 1:60,540,223...60,559,467
Ensembl chr 1:60,540,194...60,560,129
|
|
G |
Ppp5c |
protein phosphatase 5, catalytic subunit |
multiple interactions |
ISO |
[Chlorogenic Acid co-treated with Acetaminophen] results in decreased expression of PPP5C protein |
CTD |
PMID:29136249 |
|
NCBI chr 1:77,690,203...77,714,507
Ensembl chr 1:77,690,208...77,714,456
|
|
G |
Ptgs2 |
prostaglandin-endoperoxide synthase 2 |
multiple interactions |
EXP ISO |
Chlorogenic Acid inhibits the reaction [Carbon Tetrachloride results in increased expression of PTGS2 mRNA]; Chlorogenic Acid inhibits the reaction [Carbon Tetrachloride results in increased expression of PTGS2 protein]; Chlorogenic Acid inhibits the reaction [Methotrexate results in increased expression of PTGS2 protein] Chlorogenic Acid inhibits the reaction [Cisplatin results in increased expression of PTGS2 protein]; Chlorogenic Acid inhibits the reaction [Lipopolysaccharides results in increased expression of PTGS2 protein]; Chlorogenic Acid inhibits the reaction [Tetradecanoylphorbol Acetate results in increased activity of and results in increased expression of PTGS2 protein] |
CTD |
PMID:20026373 PMID:23146752 PMID:25043994 PMID:28479099 PMID:31306686 |
|
NCBI chr13:62,163,936...62,172,193
Ensembl chr13:62,163,932...62,172,188
|
|
G |
Rad23a |
RAD23 homolog A, nucleotide excision repair protein |
decreases expression |
ISO |
Chlorogenic Acid results in decreased expression of RAD23A mRNA |
CTD |
PMID:20706672 |
|
NCBI chr19:23,313,563...23,320,702
Ensembl chr19:23,314,797...23,320,695
|
|
G |
Rara |
retinoic acid receptor, alpha |
increases expression |
ISO |
Chlorogenic Acid results in increased expression of RARA mRNA |
CTD |
PMID:20706672 |
|
NCBI chr10:83,883,490...83,928,932
Ensembl chr10:83,893,384...83,928,142
|
|
G |
Rela |
RELA proto-oncogene, NF-kB subunit |
multiple interactions |
ISO |
Chlorogenic Acid inhibits the reaction [Acetaminophen results in increased expression of and results in increased phosphorylation of and affects the localization of RELA protein]; Chlorogenic Acid inhibits the reaction [Tetradecanoylphorbol Acetate results in increased activity of RELA protein] |
CTD |
PMID:20026373 PMID:26079055 |
|
NCBI chr 1:202,925,001...202,935,484
Ensembl chr 1:202,924,945...202,935,484
|
|
G |
Retreg1 |
reticulophagy regulator 1 |
multiple interactions |
EXP |
Chlorogenic Acid inhibits the reaction [Glucose results in decreased expression of RETREG1 protein] |
CTD |
PMID:34801538 |
|
NCBI chr 2:76,335,609...76,474,817
Ensembl chr 2:76,335,609...76,493,898
|
|
G |
Rtn3 |
reticulon 3 |
multiple interactions |
EXP |
Chlorogenic Acid inhibits the reaction [Glucose results in increased expression of RTN3 protein] |
CTD |
PMID:34801538 |
|
NCBI chr 1:204,612,675...204,669,212
Ensembl chr 1:204,612,675...204,669,275
|
|
G |
Rxra |
retinoid X receptor alpha |
decreases expression |
ISO |
Chlorogenic Acid results in decreased expression of RXRA mRNA |
CTD |
PMID:20706672 |
|
NCBI chr 3:10,989,832...11,076,366
Ensembl chr 3:10,989,832...11,073,712
|
|
G |
Sec62 |
SEC62 homolog, preprotein translocation factor |
multiple interactions |
EXP |
Chlorogenic Acid inhibits the reaction [Glucose results in increased expression of SEC62 protein] |
CTD |
PMID:34801538 |
|
NCBI chr 2:112,570,810...112,598,198
Ensembl chr 2:112,570,819...112,601,814
|
|
G |
Sell |
selectin L |
multiple interactions |
EXP |
[Chlorogenic Acid co-treated with lipopolysaccharide, E. coli O26-B6] results in increased expression of SELL protein; Chlorogenic Acid inhibits the reaction [lipopolysaccharide, E. coli O26-B6 results in decreased expression of SELL protein] |
CTD |
PMID:21414398 |
|
NCBI chr13:76,416,969...76,436,444
Ensembl chr13:76,416,915...76,436,456
|
|
G |
Slc11a2 |
solute carrier family 11 member 2 |
multiple interactions |
EXP |
Chlorogenic Acid inhibits the reaction [[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of SLC11A2 mRNA]; Chlorogenic Acid inhibits the reaction [[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of SLC11A2 protein] |
CTD |
PMID:31390532 |
|
NCBI chr 7:131,503,076...131,540,246
Ensembl chr 7:131,503,081...131,540,145
|
|
G |
Slc22a2 |
solute carrier family 22 member 2 |
multiple interactions |
ISO |
Chlorogenic Acid inhibits the reaction [Cisplatin results in decreased expression of SLC22A2 protein] |
CTD |
PMID:25043994 |
|
NCBI chr 1:48,121,061...48,163,268
Ensembl chr 1:48,121,061...48,163,268
|
|
G |
Slc2a4 |
solute carrier family 2 member 4 |
increases expression |
ISO |
Chlorogenic Acid results in increased expression of SLC2A4 mRNA |
CTD |
PMID:21870829 |
|
NCBI chr10:54,666,015...54,671,581
Ensembl chr10:54,666,015...54,671,565
|
|
G |
Snca |
synuclein alpha |
multiple interactions |
ISO |
Chlorogenic Acid inhibits the reaction [Rotenone results in increased expression of SNCA protein]; Chlorogenic Acid inhibits the reaction [Rotenone results in increased phosphorylation of SNCA protein] |
CTD |
PMID:36048341 |
|
NCBI chr 4:89,696,420...89,797,240
Ensembl chr 4:89,696,420...89,796,262
|
|
G |
Sod2 |
superoxide dismutase 2 |
increases expression multiple interactions |
ISO |
Chlorogenic Acid results in increased expression of SOD2 mRNA Chlorogenic Acid inhibits the reaction [sodium arsenite results in decreased expression of SOD2 mRNA] |
CTD |
PMID:33242462 |
|
NCBI chr 1:47,638,318...47,645,163
Ensembl chr 1:47,636,528...47,645,189
|
|
G |
Sod3 |
superoxide dismutase 3 |
decreases expression |
ISO |
Chlorogenic Acid results in decreased expression of SOD3 mRNA |
CTD |
PMID:20706672 |
|
NCBI chr14:58,610,104...58,615,845
Ensembl chr14:58,609,958...58,615,990
|
|
G |
Sqstm1 |
sequestosome 1 |
multiple interactions |
ISO |
Chlorogenic Acid inhibits the reaction [Acetaminophen results in decreased expression of SQSTM1 protein] |
CTD |
PMID:29136249 |
|
NCBI chr10:34,525,517...34,536,670
Ensembl chr10:34,525,519...34,536,673
|
|
G |
Srd5a2 |
steroid 5 alpha-reductase 2 |
decreases expression |
ISO |
Chlorogenic Acid results in decreased expression of SRD5A2 mRNA |
CTD |
PMID:20706672 |
|
NCBI chr 6:21,426,225...21,465,727
Ensembl chr 6:21,426,215...21,462,112
|
|
G |
Star |
steroidogenic acute regulatory protein |
increases expression |
EXP |
Chlorogenic Acid results in increased expression of STAR protein |
CTD |
PMID:29899696 |
|
NCBI chr16:66,267,094...66,274,368
Ensembl chr16:66,264,807...66,271,672
|
|
G |
Tjp1 |
tight junction protein 1 |
multiple interactions |
EXP |
Chlorogenic Acid inhibits the reaction [[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of TJP1 mRNA]; Chlorogenic Acid inhibits the reaction [[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of TJP1 protein] |
CTD |
PMID:31390532 |
|
NCBI chr 1:118,849,838...119,094,492
Ensembl chr 1:118,849,838...119,094,432
|
|
G |
Tlr3 |
toll-like receptor 3 |
multiple interactions |
ISO |
Chlorogenic Acid inhibits the reaction [Acetaminophen results in increased expression of TLR3 protein] |
CTD |
PMID:26079055 |
|
NCBI chr16:46,821,980...46,837,900
Ensembl chr16:46,822,039...46,836,545
|
|
G |
Tlr4 |
toll-like receptor 4 |
multiple interactions |
EXP ISO |
Chlorogenic Acid inhibits the reaction [Carbon Tetrachloride results in increased expression of TLR4 mRNA]; Chlorogenic Acid inhibits the reaction [Carbon Tetrachloride results in increased expression of TLR4 protein] Chlorogenic Acid inhibits the reaction [Acetaminophen results in increased expression of TLR4 protein] |
CTD |
PMID:23146752 PMID:26079055 |
|
NCBI chr 5:80,145,867...80,159,501
Ensembl chr 5:80,145,826...80,159,628
|
|
G |
Tnf |
tumor necrosis factor |
increases expression multiple interactions |
ISO EXP |
Chlorogenic Acid results in increased expression of TNF mRNA Chlorogenic Acid inhibits the reaction [Acetaminophen results in increased expression of TNF mRNA]; Chlorogenic Acid inhibits the reaction [Acetaminophen results in increased secretion of TNF protein]; Chlorogenic Acid inhibits the reaction [Cisplatin results in increased expression of TNF protein]; Chlorogenic Acid inhibits the reaction [Lipopolysaccharides results in increased secretion of TNF protein]; Chlorogenic Acid inhibits the reaction [sodium arsenite results in increased expression of TNF protein] Chlorogenic Acid inhibits the reaction [[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of TNF protein]; Chlorogenic Acid inhibits the reaction [Carbon Tetrachloride results in increased expression of TNF mRNA] |
CTD |
PMID:21870829 PMID:23146752 PMID:25043994 PMID:26079055 PMID:31306686 PMID:31390532 PMID:33242462 More...
|
|
NCBI chr20:3,622,011...3,624,629
Ensembl chr20:3,622,011...3,624,629
|
|
G |
Tp53 |
tumor protein p53 |
multiple interactions increases expression |
ISO |
Chlorogenic Acid inhibits the reaction [Cisplatin results in increased expression of TRP53 protein] Chlorogenic Acid results in increased expression of TRP53 mRNA |
CTD |
PMID:25043994 PMID:33058431 |
|
NCBI chr10:54,300,070...54,311,525
Ensembl chr10:54,300,048...54,311,524
|
|
G |
Tpt1 |
tumor protein, translationally-controlled 1 |
increases expression |
ISO |
Chlorogenic Acid results in increased expression of TPT1 mRNA |
CTD |
PMID:20706672 |
|
NCBI chr15:51,156,728...51,159,629
Ensembl chr15:51,146,154...51,159,625
|
|
G |
Traf2 |
Tnf receptor-associated factor 2 |
multiple interactions |
EXP |
Chlorogenic Acid inhibits the reaction [Glucose results in increased expression of TRAF2 protein] |
CTD |
PMID:34801538 |
|
NCBI chr 3:8,341,950...8,366,609
Ensembl chr 3:8,341,951...8,366,538
|
|
G |
Txn1 |
thioredoxin 1 |
increases expression |
ISO |
Chlorogenic Acid results in increased expression of TXN mRNA |
CTD |
PMID:20706672 |
|
NCBI chr 5:72,712,334...72,724,564
Ensembl chr 5:72,711,933...72,724,629
|
|
G |
Tyr |
tyrosinase |
increases oxidation multiple interactions |
ISO |
TYR protein results in increased oxidation of Chlorogenic Acid [TYR protein results in increased oxidation of Chlorogenic Acid] which results in decreased abundance of Glutathione |
CTD |
PMID:20685355 |
|
NCBI chr 1:141,115,036...141,210,207
Ensembl chr 1:141,115,036...141,210,207
|
|
G |
Tyrp1 |
tyrosinase-related protein 1 |
decreases expression |
ISO |
Chlorogenic Acid results in decreased expression of TYRP1 mRNA |
CTD |
PMID:20706672 |
|
NCBI chr 5:95,280,982...95,299,516
Ensembl chr 5:95,280,982...95,299,516
|
|
G |
Ugt1a1 |
UDP glucuronosyltransferase family 1 member A1 |
decreases activity |
ISO |
Chlorogenic Acid results in decreased activity of UGT1A1 protein |
CTD |
PMID:35868516 |
|
NCBI chr 9:88,801,344...88,808,465
Ensembl chr 9:88,713,184...88,808,465
|
|
G |
Ugt1a2 |
UDP glucuronosyltransferase 1 family, polypeptide A2 |
increases glucuronidation decreases activity |
ISO |
UGT1A3 protein results in increased glucuronidation of Chlorogenic Acid Chlorogenic Acid results in decreased activity of UGT1A3 protein |
CTD |
PMID:15117964 PMID:35868516 |
|
NCBI chr 9:88,791,216...88,808,465
Ensembl chr 9:88,713,184...88,808,465
|
|
G |
Ugt1a6 |
UDP glucuronosyltransferase family 1 member A6 |
decreases activity |
ISO |
Chlorogenic Acid results in decreased activity of UGT1A6 protein |
CTD |
PMID:35868516 |
|
NCBI chr 9:88,747,213...88,808,465
Ensembl chr 9:88,713,184...88,808,465
|
|
G |
Ugt1a9 |
UDP glucuronosyltransferase family 1 member A9 |
decreases activity |
ISO |
Chlorogenic Acid results in decreased activity of UGT1A9 protein |
CTD |
PMID:35868516 |
|
NCBI chr 9:88,696,981...88,808,465
Ensembl chr 9:88,713,184...88,808,465
|
|
G |
Ugt2b1 |
UDP glucuronosyltransferase 2 family, polypeptide B1 |
decreases activity |
ISO |
Chlorogenic Acid results in decreased activity of UGT2B17 protein |
CTD |
PMID:35868516 |
|
NCBI chr14:21,024,035...21,035,784
Ensembl chr14:21,024,006...21,035,986
|
|
G |
Ugt2b7 |
UDP glucuronosyltransferase family 2 member B7 |
decreases activity |
ISO |
Chlorogenic Acid results in decreased activity of UGT2B7 protein |
CTD |
PMID:35868516 |
|
NCBI chr14:20,896,682...20,919,604
Ensembl chr14:20,896,682...20,919,604
|
|
G |
Xbp1 |
X-box binding protein 1 |
multiple interactions |
EXP |
Chlorogenic Acid inhibits the reaction [Glucose results in increased expression of XBP1 mRNA] |
CTD |
PMID:34801538 |
|
NCBI chr14:80,390,629...80,395,713
Ensembl chr14:80,390,643...80,395,693
|
|